Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

William Skelly Net Worth & Insider Trades

William Skelly - Director, Acura Pharmaceuticals, Inc

As of January 5, 2023

What is William Skelly's Net Worth?

The current estimated net worth of Acura Pharmaceuticals, Inc's Director, William Skelly, is estimated to be about $352.26K . William Skelly owns about 128,345 units of Acura Pharmaceuticals, Inc common stock. In the last 14 years at Acura Pharmaceuticals, Inc, William Skelly has sold an estimated value of $226.84K worth.

What is William Skelly's Past Insider Trading?

William Skelly's largest purchase order was 100,000 units , worth over $10K on December 18, 2017. William Skelly's largest sale order was 10,000 units , worth over $39K on November 9, 2011. In total, William Skelly has made about 35 transactions over 14 years of their time at Acura Pharmaceuticals, Inc. William Skelly usually trades in January and May, with the busiest year in 2013.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

William Skelly

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is William Skelly's' Mailing Address?

  • Mailing address is C/o Acura Pharmaceuticals, Inc. 616 N. North Court, Suite 120 Palatine IL 60067 IL

What are Acura Pharmaceuticals, Inc's Past Insider Trades?

Acura Pharmaceuticals, Inc's most recent insider trade came on January 2, 2018 by Claudius Llc, International Partners Galen III, Galen Employee Fund Iii Lp, Galen Management Llc and Partners Galen III who sold 2,195,734 units worth $219.57K . In the last 9 years, insiders at Acura Pharmaceuticals, Inc have sold an estimated value of $25.32M and bought an estimated value of $15.01M worth of shares. Insider trading is most common in January, with the busiest year in 2013. The most active traders at the company are Care Capital Ii Llc,  Care Capital Investments Ii Lp,  and Care Capital Offshore Investments Ii Lp .

ACURA PHARMACEUTICALS, INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...